⌕
Scribe Therapeutics · SCTX · Nasdaq
Tenet — · insufficient data
Compare
$15.37−6.05%At close
$15.37−0.99 (−6.05%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

Scribe Therapeutics (SCTX) Institutional Ownership

Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.

Sources Ownership filingsHow we compute thisNot investment advice
The 13F summary for SCTX is still being assembled from the full list of filers and was not ready when this page was built. It appears on a reload in a few minutes. No partial count is shown in its place, so that part of a quarter is never read as all of it.
routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
DateNameRoleTypeSharesPriceSEC filing
Jul 28, 2026Aghazadeh BehzaddirectorAcquired · Open-market buy7,905$18.25↗
Jul 27, 2026AH Bio Fund II, L.P.10% ownerAcquired · Derivative conversion2,051,742—↗
Jul 27, 2026AH Bio Fund II, L.P.10% ownerAcquired · Derivative conversion697,650—↗
Jul 27, 2026AH Bio Fund II, L.P.10% ownerAcquired · Open-market buy333,333$15.00↗
Jul 27, 2026AH Bio Fund II, L.P.10% ownerDisposed · Derivative conversion12,150,003Series A Preferred Stock—↗
Jul 27, 2026AH Bio Fund II, L.P.10% ownerDisposed · Derivative conversion4,131,344Series B Preferred Stock—↗
Jul 27, 2026GORDON CARL LdirectorAcquired · Derivative conversion348,825—↗
Jul 27, 2026GORDON CARL LdirectorAcquired · Open-market buy1,000,000$15.00↗
Jul 27, 2026GORDON CARL LdirectorDisposed · Derivative conversion2,065,672Series B Preferred Stock—↗
Jul 27, 2026ORBIMED ADVISORS LLCdirectorAcquired · Derivative conversion348,825—↗
Jul 27, 2026ORBIMED ADVISORS LLCdirectorAcquired · Open-market buy1,000,000$15.00↗
Jul 27, 2026ORBIMED ADVISORS LLCdirectorDisposed · Derivative conversion2,065,672Series B Preferred Stock—↗
Jul 27, 2026Doudna Jennifer A10% ownerAcquired · Derivative conversion12,511—↗
Jul 27, 2026Doudna Jennifer A10% ownerDisposed · Derivative conversion74,088Series A-1 Preferred Stock—↗
Jul 24, 2026Aghazadeh BehzaddirectorAcquired · Open-market buy2,333,333$15.00↗
Jul 24, 2026Aghazadeh BehzaddirectorAcquired · Open-market buy50,000$22.31↗
Jul 23, 2026Staahl Brett10% ownerAcquired · Grant / award19,385Stock Option (Right to Buy)—↗
Jul 23, 2026Staahl Brett10% ownerAcquired · Grant / award19,385Performance-based Stock Option (Right to Buy)—↗
Jul 23, 2026Lucas SvetlanaChief Business OfficerAcquired · Open-market buy3,000$15.00↗
Jul 23, 2026Lucas SvetlanaChief Business OfficerAcquired · Grant / award109,426Stock Option (Right to Buy)—↗

13F holdings are reported quarterly; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.

** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.

Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.